Arkolith/Insider Trading/AMAM/Form 4

Cormorant Private Healthcare Fund III LP

10% OwnerAmbrx Biopharma Inc. (AMAM) · full profile →Form 4 · filed Mar 16, 2023
Net Buying
Open-Market Buys
$10.2M
Open-Market Sells
$0
Net Open-Market Flow
$10.2M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 16, 2023Buy(P)500K$10.15$5.1M53.5M
Mar 15, 2023Buy(P)250K$10.60$2.6M53.0M
Mar 14, 2023Buy(P)250K$9.95$2.5M52.8M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000929638-23-000867) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML